Proteolysis-focusing on chimeras (PROTACs) and molecular glue degraders (MGDs) are probably the most maturely formulated TPD procedures. In this particular overview, we focus on each preclinical experiments and scientific trials to provide a comprehensive summary of the safety and medical success of PROTACs and MGDs in hematologic malignancies over the https://ro512676613468.link4blogs.com/53465180/abbv-744-no-further-a-mystery